Viatris, Inc (VTRS)

Viatris, Inc (VTRS)


Charts by TradingView

Pricing is indicative. Past performance is not a reliable indicator of future results. Log in to see latest markets data.

Viatris, Inc (VTRS) Profile

Viatris Inc. is an American global healthcare company headquartered in Canonsburg, Pennsylvania. The company was formed through the merger of Mylan and Upjohn on November 16, 2020. Viatris ranked 254th on the 2021 Fortune 500 rankings of the largest United States corporations by total revenue. Viatris announced a cost-reducing restructuring plan which would impact up to 20% of its global workforce, or 9,000 jobs at its facilities around the world. The company reported in the first quarter of 2021 USD 4.4M in earnings, which is up 70% year over year, with a gross profit margin of 59.6%, up from 52.7% in the same period in 2020. The company is well suited to add biosimilars and complex generics to its arsenal, driving up revenue. It already has 1,400 approved molecules across a range of therapies, and it has recently come up with several new ones. In March 2021, it got tentative approval from the Food and Drug Administration (FDA) for an abbreviated new drug application (ANDA) for a generic version of Symbicort, which is indicated for patients with asthma or chronic obstructive pulmonary disease. The drug brought in USD 2.7B in revenue last year for AstraZeneca.

Holding cost
Largos
-5%
Cortos
-2.5%
Trading hours in US Eastern Time
Fri
16:30-23:00
Mon
16:30-23:00
Tue
16:30-23:00
Wed
16:30-23:00
Thu
16:30-23:00
Sun
Cierra
Sat
Cierra

Start Trading Viatris, Inc (VTRS)
with a Market Leader Today

Share CFD Trading FAQ

Each investor owning shares of a company is also owning fragments of the company. A quite simple way to explain what a stock is is basically when a company divides itself into several shares and then it makes a part of these equities available to the public, at a price. Each investor owning shares of a company is owning fragments of the company.

While shares represent units of ownership within a company Contracts for Difference (CFDs) allow traders to speculate on the future share price fluctuations of an underlying asset. Thus when trading CFDs traders do not physically own the underlying asset. CFDs are available for a range of underlying assets, such as acciones, commodities, y foreign exchange, y índices.

6 razones para operar CFD sobre acciones con FP Markets

Regulado en Australia
Bróker de forex y CFD

A largo o a corto

Increase your ability to profit in all market conditions Leverage options up to 20:1

Ejecución DMA
(Acceso directo al mercado)

Precios de acciones transparentes
y en tiempo real Control, funcionalidad y liquidez abundante
Total profundidad de mercado
y vista de órdenes en la cola

Plataformas avanzadas
& Technology

MT4, MT5, Webtrader & Iress with superior client portal

Soporte multilingüe 24/7

Award winning support & personal account managers

Exposición global

Márgenes bajos y comisiones competitivas en +10.000 productos en acciones globales en cuatro continentes

Gana dividendos

On long positions No ownership of physical shares necessary

Empieza a hacer trading
en cuestión de minutos.

Abre una cuenta ahora

bullet Accede a más de 10.000 instrumentos financieros
bullet Apertura y cierre automático de posiciones
bullet Noticias y agenda económica
bullet Indicadores técnicos y gráficos
bullet Muchas más herramientas incluidas

Al proporcionar su correo electrónico, usted acepta la política de privacidad de FP Markets y está de acuerdo en recibir futuros mensajes de marketing por parte de FP Markets. Puede darse de baja en cualquier momento.





Get instant Updates in Telegram
Mapa del sitio | © FP Markets 2022